Shayman; James A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shayman; James A..The latest application filed is for "glucosylceramide synthase inhibitors and therapeutic methods using the same".

Company Profile

0.26.23

Shayman; James A. - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucosylceramide synthase inhibitors and therapeutic methods using the same Grant 11,220,479 - Larsen , et al. January 11, 2	2022-01-11
Glucosylceramide Synthase Inhibitors And Therapeutic Methods Using The Same App 20210122712 - Larsen; Scott D. ; et al.	2021-04-29
Glucosylceramide synthase inhibitors and therapeutic methods using the same Grant 10,202,340 - Larsen , et al. Feb	2019-02-12
Method of reducing accumulation of intracellular tingible body macrophages Grant 10,111,937 - Shayman , et al. October 30, 2	2018-10-30
Glucosylceramide Synthase Inhibitors And Therapeutic Methods Using The Same App 20180022697 - Larsen; Scott D. ; et al.	2018-01-25
Lysosomal Phospholipase A2 (LPLA2) Activity as a Diagnostic and Therapeutic Target for Identifying and Treating Systemic Lupus Erythematosus App 20160317626 - Shayman; James A. ; et al.	2016-11-03
Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus Grant 9,309,553 - Shayman , et al. April 12, 2	2016-04-12
Glucosylceramide synthase inhibitors and therapeutic methods using the same Grant 8,961,959 - Larsen , et al. February 24, 2	2015-02-24
Glucosylceramide Synthase Inhibitors And Therapeutic Methods Using The Same App 20130095089 - Larsen; Scott ; et al.	2013-04-18
Lysosomal Phospholipase A2 (LPLA2) Activity as a Diagnostic and Therapeutic Target for Identifying and treating Systemic Lupus Erythematosis App 20120121571 - Shayman; James A. ; et al.	2012-05-17
Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis Grant 8,052,970 - Shayman , et al. November 8, 2	2011-11-08
Lysosomal Phospholipase A2 (lpla2) Activity As A Diagnostic And Therapeutic Target For Identifying And Treating Systemic Lupus Erythematosis App 20090324575 - Shayman; James A. ; et al.	2009-12-31
Amino ceramide-like compounds and therapeutic methods of use App 20090312392 - Shayman; James A. ; et al.	2009-12-17
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant 7,615,573 - Siegel , et al. November 10, 2	2009-11-10
Methods and compositions for using aleveolar macrophage phospholipase A2 Grant 7,582,442 - Shayman , et al. September 1, 2	2009-09-01
Amino ceramide-like compounds and therapeutic methods of use App 20080146533 - Shayman; James A. ; et al.	2008-06-19
Amino ceramide-like compounds and therapeutic methods of use Grant 7,335,681 - Shayman February 26, 2	2008-02-26
Methods and compositions for using alveolar macrophage phospholipase A2 Grant 7,319,015 - Shayman , et al. January 15, 2	2008-01-15
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors App 20070203223 - Siegel; Craig ; et al.	2007-08-30
Amino ceramide-like compounds and therapeutic methods of use Grant 7,253,185 - Shayman , et al. August 7, 2	2007-08-07
Amino ceramide-like compounds and therapeutic methods of use App 20070072916 - Shayman; James A.	2007-03-29
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors Grant 7,196,205 - Siegel , et al. March 27, 2	2007-03-27
Amino ceramide-like compounds and therapeutic methods of use Grant 7,148,251 - Shayman December 12, 2	2006-12-12
Amino ceramide-like compounds and therapeutic methods of use App 20060217560 - Shayman; James A.	2006-09-28
Methods and compositions for using aleveolar macrophage phospholipase A2 App 20060008455 - Shayman; James A. ; et al.	2006-01-12
Methods and compositions for using aleveolar macrophage phospholipase A2 App 20050281803 - Shayman, James A. ; et al.	2005-12-22
Amino ceramide-like compounds and therapeutic methods of use App 20050267094 - Shayman, James A. ; et al.	2005-12-01
Amino ceramide-like compounds and therapeutic methods of use App 20050239862 - Shayman, James A. ; et al.	2005-10-27
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors App 20050222244 - Siegel, Craig ; et al.	2005-10-06
Amino ceramide-like compounds and therapeutic methods of use Grant 6,916,802 - Shayman , et al. July 12, 2	2005-07-12
Amino ceramide-like compounds and therapeutic methods of use Grant 6,890,949 - Shayman , et al. May 10, 2	2005-05-10
Amino ceramide-like compounds and therapeutic methods of use App 20050049235 - Shayman, James A. ; et al.	2005-03-03
Amino ceramide-like compounds and therapeutic methods of use App 20040260099 - Shayman, James A.	2004-12-23
Compositions and methods for treating autoimmune disease App 20030119789 - Holoshitz, Joseph ; et al.	2003-06-26
Amino ceramide-like compounds and therapeutic methods of use Grant 6,569,889 - Shayman , et al. May 27, 2	2003-05-27
Amino ceramide-like compounds and therapeutic methods of use App 20030073680 - Shayman, James A. ; et al.	2003-04-17
Compositions for treating autoimmune disease Grant 6,518,259 - Holoshitz , et al. February 11, 2	2003-02-11
Amino ceramide - like compounds and therapeutic methods of use App 20020198240 - Shayman, James A. ; et al.	2002-12-26
Amino ceramide - like compounds and therapeutic methods of use App 20020156107 - Shayman, James A. ; et al.	2002-10-24
Amino ceramide - like compounds and therapeutic methods of use App 20010041735 - Shayman, James A. ; et al.	2001-11-15
Amino ceramide-like compounds and therapeutic methods of use Grant 6,255,336 - Shayman , et al. July 3, 2	2001-07-03
Amino ceramide-like compounds and therapeutic methods of use Grant 6,051,598 - Shayman , et al. April 18, 2	2000-04-18
Amino ceramide-like compounds and therapeutic methods of use Grant 6,040,332 - Shayman , et al. March 21, 2	2000-03-21
Amino ceramide-like compounds and therapeutic methods of use Grant 6,030,995 - Shayman , et al. February 29, 2	2000-02-29
Amino ceramide-like compounds and therapeutic methods of use Grant 5,952,370 - Shayman , et al. September 14, 1	1999-09-14
Amino ceramide-like compounds and therapeutic methods of use Grant 5,945,442 - Shayman , et al. August 31, 1	1999-08-31
Amino ceramide--like compounds and therapeutic methods of use Grant 5,916,911 - Shayman , et al. June 29, 1	1999-06-29
Treatment of diabetic nephropathy Grant 5,302,609 - Shayman , et al. April 12, 1	1994-04-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.